SPEAKSpeech Supplementation for Children with Cerebral Palsy
AAC Speech supplementation
Behavior+7
+ Brain Damage, Chronic
+ Brain Diseases
Treatment Study
Summary
Study start date: February 1, 2026
Actual date on which the first participant was enrolled.This study focuses on improving communication abilities in children with cerebral palsy who have difficulty being understood when they speak, a condition known as dysarthria. It aims to test a communication method called speech supplementation, which can help make speech clearer and easier to understand. The study will include 100 children with cerebral palsy, teaching them to use a communication board to point to the first letter of each word or relevant pictures while speaking. This approach can help listeners better understand what the children are saying, which is crucial for their social interactions and learning. Participants in the study will first record 60 sentences to establish a baseline of their usual speech. They will then receive one-on-one training to learn the speech supplementation technique. Once they have mastered it, they will record the same sentences using the new method. These recordings will be evaluated by two groups of listeners. The first group will transcribe the sentences to see how many words they can correctly identify, while the second group will rate how understandable the speech is on a scale. Comparing the results from before and after the intervention will show how effective the speech supplementation is in improving clarity. This could lead to better communication strategies for children with speech difficulties.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 7 to 17 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location